Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy

医学 闭塞 大脑中动脉 纸牌密码算法 外科 心脏病学 缺血性中风 改良兰金量表 缺血
作者
Justus F. Kleine,Silke Wunderlich,Claus Zimmer,Johannes Kaesmacher
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:9 (2): 117-121 被引量:175
标识
DOI:10.1136/neurintsurg-2015-012218
摘要

Background The Thrombolysis in Cerebral Infarction (TICI) scale is the most widely applied scoring system to grade technical results of recanalizing therapies in acute ischemic stroke (AIS). TICI 2b and TICI 3 are conventionally subsumed as ‘successful recanalization’. Previous studies reported conflicting results for the clinical relevance of achieving complete (TICI 3) versus ‘almost’ complete reperfusion (TICI 2b). Objective To examine if neurologic outcome differs significantly between TICI 2b and TICI 3 in patients with AIS with middle cerebral artery (MCA) occlusion treated ‘successfully’ with mechanical thrombectomy (MTE). Methods Retrospective analysis of prospectively collected data from 352 consecutive patients with isolated MCA occlusion subjected to MTE between January 2007 and July 2015. Results 262 of the 277 successfully treated patients had adequate follow-up and were included. Patients (n=119) in the TICI 3 group had a lower National Institutes of Health Stroke Scale score at discharge (NIHSS-DIS; median 5 vs 7, p=0.005), and showed higher rates of strong neurologic improvement (ΔNIHSS≥8 or NIHSS-DIS≤1, 68.4% vs 37.1%, p=0.002) and favorable NIHSS outcome (NIHSS-DIS≤5, 49.2% vs 31.9%, p=0.005). Hospital stays were shorter in the TICI 3 group (median 10 vs 12 days, p=0.014). After adjusting for relevant baseline and treatment parameters, TICI 3 was independently associated with strong neurologic improvement (OR=4.3, 95% CI 2.2 to 8.3, p<0.001) and favorable NIHSS outcome (OR=3.0, 95% CI 1.5 to 6.3, p=0.003). Conclusions Neurologic outcome is substantially better in TICI 3 than TICI 2b patients, and hospital stays are shorter. Endovascular strategies that consequently strive to achieve TICI 3 may be warranted and cost-effective, and should be examined by future research. TICI 3 rates should be included as a safety measure in studies evaluating MTE devices and techniques.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xueym完成签到 ,获得积分10
3秒前
leilei完成签到,获得积分10
4秒前
luobote完成签到 ,获得积分10
4秒前
吉吉完成签到,获得积分10
4秒前
凡凡完成签到,获得积分10
10秒前
花花2024完成签到 ,获得积分10
12秒前
梦游菌完成签到 ,获得积分10
13秒前
诚心天晴完成签到 ,获得积分10
15秒前
17秒前
nie完成签到 ,获得积分10
23秒前
桃花源的瓶起子完成签到 ,获得积分10
23秒前
可爱可愁完成签到,获得积分10
24秒前
Sew东坡发布了新的文献求助10
24秒前
顶顶顶完成签到 ,获得积分10
30秒前
舍弃完成签到,获得积分10
37秒前
马冬梅完成签到 ,获得积分10
39秒前
忧虑的靖巧完成签到 ,获得积分0
41秒前
奋斗诗云完成签到 ,获得积分10
42秒前
点点发布了新的文献求助10
45秒前
秋秋完成签到 ,获得积分10
48秒前
Guofa.完成签到 ,获得积分10
56秒前
吉吉国王完成签到 ,获得积分10
57秒前
小小马完成签到 ,获得积分10
59秒前
Ava应助一个小胖子采纳,获得10
1分钟前
1分钟前
HY完成签到 ,获得积分10
1分钟前
1分钟前
Laser_eyes完成签到,获得积分10
1分钟前
Andy完成签到 ,获得积分10
1分钟前
传奇3应助xuxu213采纳,获得10
1分钟前
1分钟前
科研通AI6.2应助Brave采纳,获得10
1分钟前
兰花二狗他爹完成签到,获得积分0
1分钟前
忆_完成签到 ,获得积分10
1分钟前
贪玩初彤完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
从容白开水完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
The Cambridge History of China 英文版16册 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7331544
求助须知:如何正确求助?哪些是违规求助? 8945968
关于积分的说明 18975256
捐赠科研通 6985837
什么是DOI,文献DOI怎么找? 3216880
关于科研通互助平台的介绍 2383416
邀请新用户注册赠送积分活动 2196527